Kuang-Chi Technologies Co., Ltd. (SHE:002625)
China · Delayed Price · Currency is CNY 40.30
-0.56 (-1.37%)
Aug 1, 2025, 3:04 PM CST
Verve Therapeutics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 666.66 | 651.97 | 583.3 | 376.68 | 271.27 | 163.17 | Upgrade |
Depreciation & Amortization | 124.17 | 124.17 | 119.61 | 121.57 | 100.04 | 57.64 | Upgrade |
Other Amortization | 5.59 | 5.59 | 5.5 | 4.93 | 4.7 | 10.25 | Upgrade |
Loss (Gain) From Sale of Assets | -0.04 | -0.04 | -0.75 | 23.26 | -0.65 | -6.88 | Upgrade |
Asset Writedown & Restructuring Costs | 0 | 0 | 32.53 | 9.33 | 3.23 | 8.74 | Upgrade |
Loss (Gain) From Sale of Investments | -0.25 | -0.25 | -16.39 | -2.42 | -17.6 | -18.5 | Upgrade |
Provision & Write-off of Bad Debts | 64.16 | 64.16 | 17.02 | 20.11 | 37.82 | 28.39 | Upgrade |
Other Operating Activities | 219.78 | -157.08 | -148.83 | -154.85 | -113.29 | -38.39 | Upgrade |
Change in Accounts Receivable | -781.82 | -781.82 | -513.57 | -250.1 | -407.49 | -224.67 | Upgrade |
Change in Inventory | 24.72 | 24.72 | 165.61 | -160.49 | -249.68 | -48.7 | Upgrade |
Change in Accounts Payable | -3.13 | -3.13 | -253.76 | 155.5 | 270.49 | 89.35 | Upgrade |
Change in Other Net Operating Assets | 0.59 | 0.59 | 1.58 | -0.25 | 9.55 | -0.9 | Upgrade |
Operating Cash Flow | 305.54 | -86.02 | -15.88 | 140.9 | -92.76 | 11.68 | Upgrade |
Operating Cash Flow Growth | - | - | - | - | - | -87.68% | Upgrade |
Capital Expenditures | -569.13 | -630.44 | -427.9 | -383.65 | -348.1 | -261.64 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 18.62 | 36.13 | 0.06 | 24.32 | Upgrade |
Divestitures | - | - | 491.08 | - | -0 | - | Upgrade |
Investment in Securities | -0 | -0 | - | 246.98 | -212.93 | 2,427 | Upgrade |
Other Investing Activities | 156.14 | 123.88 | 25.96 | 82.4 | 165.56 | 16.46 | Upgrade |
Investing Cash Flow | -412.99 | -506.56 | 107.75 | -18.15 | -395.42 | 2,207 | Upgrade |
Short-Term Debt Issued | - | - | - | 400 | - | 540 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 30 | - | Upgrade |
Total Debt Issued | - | - | - | 400 | 30 | 540 | Upgrade |
Short-Term Debt Repaid | - | - | - | -400 | - | -200 | Upgrade |
Long-Term Debt Repaid | - | -4.37 | -5.28 | -9.25 | -379.79 | - | Upgrade |
Total Debt Repaid | -4.37 | -4.37 | -5.28 | -409.25 | -379.79 | -200 | Upgrade |
Net Debt Issued (Repaid) | -4.37 | -4.37 | -5.28 | -9.25 | -349.79 | 340 | Upgrade |
Issuance of Common Stock | 28.8 | 28.46 | - | - | - | - | Upgrade |
Repurchase of Common Stock | -65.9 | -65.9 | - | - | - | - | Upgrade |
Common Dividends Paid | -500.84 | -500.84 | - | -290.87 | -4.13 | -10.51 | Upgrade |
Other Financing Activities | 32.84 | -11.34 | -0.68 | -0.27 | - | 0.97 | Upgrade |
Financing Cash Flow | -509.46 | -553.98 | -5.96 | -300.39 | -353.92 | 330.45 | Upgrade |
Net Cash Flow | -616.92 | -1,147 | 85.91 | -177.63 | -842.1 | 2,549 | Upgrade |
Free Cash Flow | -263.59 | -716.46 | -443.78 | -242.75 | -440.86 | -249.96 | Upgrade |
Free Cash Flow Margin | -16.38% | -45.99% | -29.70% | -20.79% | -51.30% | -39.27% | Upgrade |
Free Cash Flow Per Share | -0.12 | -0.33 | -0.20 | -0.11 | -0.21 | -0.12 | Upgrade |
Cash Interest Paid | - | - | - | 0.93 | - | - | Upgrade |
Cash Income Tax Paid | 264.38 | 285.87 | 217.54 | 66.73 | 41.61 | 20.66 | Upgrade |
Levered Free Cash Flow | -209.14 | -805.77 | -274.31 | -189.11 | -476.07 | -434.27 | Upgrade |
Unlevered Free Cash Flow | -209.14 | -805.77 | -274.31 | -188.52 | -473.77 | -428.02 | Upgrade |
Change in Net Working Capital | 145.69 | 664.93 | 266.75 | 87.69 | 328.01 | 270.25 | Upgrade |
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.